Why It's Already Time To Invest In The Disc Replacement Revolution

The AxioMed viscoelastic total disc replacement (TDR) has a leading role to play in building a sustainable future for spine surgery globally. Why do we think so? AxioMed has a unique viscoelastic technology and proven clinical track record internationally in Europe, Australia and the Caribbean. There has never been a device failure of an AxioMed disc implanted. Long term data in contrast show heterotopic ossification (HO) and device failures of ball-and-socket artificial disc replacement (ADR) spacers and the M6 embroidered disc. We anticipate that countries such as India, Japan and China will be attracted to the safety and performance advantages of AxioMed.

More and more investors are showing signs that it is time to invest in disc replacement. Nuvasive recently acquired the Simplify cervical disc replacement before the ink could dry on the FDA clearance and are reporting rapid adoption. Zimmer paid $1+ Billion to acquire the Mobic-C disc replacement in their acquisition of LDR. In April of 2020, Zimmer Biomet Spine announced the implantation of over 150,000 of Mobic-C. Health insurance providers once unanimously considered lumbar disc replacement an investigational procedure. Today insurers are covering disc replacement. These include

• Anthem

• Cigna

• Some of the Blue Cross Blue Shield plans

• Humana

• TriCare

• Molina Healthcare Inc

• Unitedhealthcare

  *Eligibility may vary from patient to patient

“The spine surgery industry is heading to an unsustainable future as the current giant companies invest in expensive navigation and robotics technologies to help American surgeons place pedicle screws to encourage longer and longer fusion constructs to stop motion of the spine and replace the disc with metal interbody fusion cages.” says Dr. Kingsley R Chin, a board-certified professor of orthopedic spine surgery and CEO of KICVentures Group Inc.

KICVentures Group Investing and Advancing Healthcare Technologies
Contact us at INVESTOR@KICventures.com

About AxioMed
AxioMed was founded in 2001 by surgeons at Cleveland Clinic and engineers who previously worked with Dr. Art Steffee and Acroflex viscoelastic disc replacement. The current AxioMed disc comprises of a proprietary silica-based viscoelastic material proven in extensive biomedical/biocompatible testing to mimic the human disc in all planes and 50+ years of longevity testing. The viscoelastic material is radiolucent and thus X-ray and MRI compatible. Over 800 discs have been implanted worldwide with zero failures or revisions. It is the only viscoelastic lumbar disc to complete a USA IDE clinical study with 10+ years of follow-up. AxioMed is also the only company pursuing 3 level Cervical Disc and Lateral Lumbar Disc IDE clinical studies for FDA clearance. AxioMed has years of international experience with positive data showing its effectiveness in multilevel cervical and lumbar disc replacement surgeries (up to 4 levels).
http://www.AxioMed.com

About KICVentures Group
Founded in 2000 makes us the most experienced healthcare investment holding company with the largest portfolio of medical device technologies focused on solutions for less invasive outpatient spine surgery. Our investment strategy is to acquire or invent disruptive technologies using our own capital or partner with private individual investors. This allows us the freedom to make quick and nimble decisions such as when we acquired AxioMed Viscoelastic Disc Technologies while other firms invested in ball-and-socket articulating spacers.
http://www.KICVenturesGroup.com

References

• Which Insurance Providers Cover Lumbar Artificial Disc Replacement

• Positive US Payer Decisions Expected to Drive Artificial Disc Replacement Market

• Incidence of Fusion Across Total Disc Replacement With Heterotopic Ossification: Are Ball and Socket Disk Replacements Fusing With and Without Radiographic Evidence

• Clinical experience and two-year follow-up with a one-piece viscoelastic cervical total disc replacement

• Preclinical and clinical experience with a viscoelastic total disc replacement​

• Viscoelastic Disc Arthroplasty Provides Superior Back and Leg Pain Relief in Patients with Lumbar Disc Degeneration Compared to Anterior Lumbar Interbody Fusion

• Osteolysis, Infection Reported In M6-C, Prestige Cervical Discs

Authors

Dr. Kingsley R. Chin MBA is a board-certified Professor of Orthopedic Spine Surgery and honors graduate of Harvard Medical School and the Harvard Combined Orthopedic Residency Program. He did his spine fellowship with Dr. Henry H Bohlman. He was Chief of Spine Surgery at the University of Pennsylvania.

Dr. Jason A. Seale is a medical doctor and entrepreneur. He is the clinical director at the LES Clinic. He holds a Masters in Business Administration degree